Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) Stock
Stocks
RMDA
EGS381B1C015
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.960 EGP | -0.20% |
|
-2.55% | +48.95% |
| 05-19 | Egypt's Rameda Q1 standalone profit EGP 105.2 million | RE |
| 05-19 | Rameda FY dividend/share EGP 0.03 | RE |
| Market Cap | 9.92B 196M 171M 158M 146M 275M 18.78B 280M 1.88B 739M 9.2B 734M 718M 31.67B | P/E 2026 * |
18x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11.93B 235M 206M 190M 176M 331M 22.59B 337M 2.27B 889M 11.06B 883M 864M 38.09B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 2.07x |
| Free-Float |
41.49% | Yield 2026 * |
1.28% | Yield 2027 * | 3.12% |
| 1 day | -0.20% | ||
| 1 week | -2.55% | ||
| Current month | +0.20% | ||
| 1 month | -4.98% | ||
| 3 months | +12.47% | ||
| 6 months | +58.97% | ||
| Current year | +48.95% |
| 1 week | 4.94 |  | 5.03 |
| 1 month | 4.81 | | 5.16 |
| Current year | 3.06 | | 5.38 |
| 1 year | 3.02 | | 5.38 |
| 3 years | 0.99 | | 5.38 |
| 5 years | 0.8 | | 5.38 |
| 10 years | 0.8 | | 5.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 2010-12-31 |
Aboamira Mohamed
DFI | Director of Finance/CFO | - | 2014-07-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 2018-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Karim Zahran
BRD | Director/Board Member | 41 | 2017-12-31 |
Ayman Abbas
CHM | Chairman | 51 | 2010-12-31 |
Amr Morsy
BRD | Director/Board Member | - | 2010-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | -2.55% | +44.61% | +348.22% | 196M | |
| -1.11% | -5.85% | +48.32% | +156.00% | 1,028B | |
| -1.28% | -4.66% | +61.83% | +57.86% | 611B | |
| +1.52% | -2.15% | +32.68% | +83.42% | 432B | |
| +0.98% | -1.40% | +29.49% | +23.12% | 323B | |
| -0.34% | -3.10% | +27.00% | +43.66% | 277B | |
| +1.63% | -11.76% | +19.72% | +23.20% | 257B | |
| +3.39% | +2.29% | -23.68% | -38.33% | 217B | |
| +1.14% | -2.25% | +22.97% | +57.88% | 192B | |
| +2.01% | -2.33% | +21.63% | +71.21% | 161B | |
| Average | +0.82% | -4.76% | +28.46% | +82.62% | 349.85B | |
| Weighted average by Cap. | +0.25% | -5.52% | +36.14% | +77.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.78B 94.22M 82.34M 76.12M 70.32M 132M 9.05B 135M 908M 356M 4.43B 354M 346M 15.26B | 5.63B 111M 96.98M 89.65M 82.83M 156M 10.66B 159M 1.07B 419M 5.22B 417M 408M 17.97B |
| Net income | 564M 11.12M 9.72M 8.98M 8.3M 15.63M 1.07B 15.92M 107M 42.04M 523M 41.78M 40.85M 1.8B | 815M 16.07M 14.04M 12.98M 11.99M 22.58M 1.54B 22.99M 155M 60.74M 756M 60.36M 59.02M 2.6B |
| Net Debt | 2.01B 39.64M 34.64M 32.02M 29.58M 55.71M 3.81B 56.72M 382M 150M 1.86B 149M 146M 6.42B | 1.72B 33.95M 29.67M 27.43M 25.34M 47.72M 3.26B 48.58M 327M 128M 1.6B 128M 125M 5.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | EGP 4.960 | -0.20% | 3,252,288 |
| 26-07-13 | EGP 4.970 | -0.60% | 4,038,987 |
| 26-07-12 | EGP 5.000 | +0.20% | 1,728,889 |
| 26-07-09 | EGP 4.990 | +0.20% | 1,948,541 |
| 26-07-08 | EGP 4.980 | -2.16% | 4,732,470 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMDA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
